Companies House · 04082256

BROWN & BURK UK LIMITED

UK registered company, private limited company, incorporated 2 Oct 2000.

Active
44
Public contracts
0
Spend payments
Total spend

BROWN & BURK UK LIMITED is a UK company registered at Companies House under number 04082256. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
04082256
Status
Active
Company type
Private Limited Company
Incorporated
2 Oct 2000
Country of origin
United Kingdom
Registered office
MICRO HOUSE, HOUNSLOW, MIDDLESEX, TW4 5DQ
Nature of business (SIC)
21200 - Manufacture of pharmaceutical preparations
Accounts category
FULL
View source on data.gov.uk

Public sector contracts

Contract awards linked to BROWN & BURK UK LIMITED.

ProcurementBuyerAwardedValue
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Pharmaceuticals Transition 2021_3The NHS Commissioning Board (operating under the name of NHS England)
NHS National Generic Pharmaceuticals Wave 13The NHS Commissioning Board (operating under the name of NHS England)
NHS National Generic Pharmaceuticals Wave 13The NHS Commissioning Board (operating under the name of NHS England)
NHS National Generic Pharmaceuticals Wave 14aNHS England
NHS National Generic Pharmaceuticals Interim 2 2020The NHS Commissioning Board (operating under the name of NHS England)
NHS National Generic Pharmaceuticals Transition 2021_1The NHS Commissioning Board (operating under the name of NHS England)
Generic Drugs - Tablets & CapsulesVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)
NHS National Pharmaceuticals Transition 2023_1NHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generic Pharmaceuticals Wave 14cNHS England
NHS National Generic Pharmaceuticals Wave 14cNHS England
NHS National Generic Pharmaceuticals Wave 14cNHS England
Generic Drugs - Tablets & CapsulesVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services ( on behalf of All LHB's and Trusts )
NHS National Generic Pharmaceuticals Wave 15aNHS England
NHS National Generic Pharmaceuticals Wave 15aNHS England
NHS National Generic Pharmaceuticals Wave 15bNHS England
NHS National Generic Pharmaceuticals Wave 15bNHS England
NHS national Generic Pharmaceuticals Transition 2021_2The NHS Commissioning Board (operating under the name of NHS England)
NHS national Generic Pharmaceuticals Transition 2021_2The NHS Commissioning Board (operating under the name of NHS England)
NHS national Generic Pharmaceuticals Transition 2021_2The NHS Commissioning Board (operating under the name of NHS England)
NHS national Generic Pharmaceuticals Transition 2021_2The NHS Commissioning Board (operating under the name of NHS England)
NHS national Generic Pharmaceuticals Transition 2021_2The NHS Commissioning Board (operating under the name of NHS England)
NHS national Generic Pharmaceuticals Transition 2021_2The NHS Commissioning Board (operating under the name of NHS England)
NHS National Generics Pharmaceuticals - Supply Chain ResilienceNHS England30 Apr 2026£35m
NHS Generic Pharmaceuticals - Wave 15cNHS England13 Jan 2026£403.7m
NHS Generic Pharmaceuticals - Wave 15cNHS England13 Jan 2026£17.7m
NHS National Framework for Generics HousekeepingNHS England10 Nov 2025£17.8m
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2)NHS England4 Mar 2024£1
NHS National Generic Pharmaceuticals Wave 14bATAMIS LTD6 Jul 2023£428.2m
NHS National Generics Pharmaceuticals Transition 2023_1NHS england4 May 2023£57.6m
NHS National Generic Pharmaceuticals Wave 14aNHS England14 Dec 2022£208m
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD30 Nov 2021£469.7m
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD30 Nov 2021£469.7m
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD30 Nov 2021£469.7m
NHS National Pharmaceuticals Transition 2021_3NHS England21 Oct 2021£26m
NHS National Generic Pharmaceuticals - Transition 2021_2NHS England31 Mar 2021£2.8m
NHS National Generic Pharmaceuticals- Transition 2021_1NHS England3 Mar 2021£8.9m
NHS National Generic Pharmaceuticals Interim 2NHS England21 Dec 2020£12.3m
NHS National Generic Pharmaceuticals Interim 2NHS England21 Dec 2020£12.3m

Supplier identities

How this company appears as a supplier across the data.

FAQs about BROWN & BURK UK LIMITED

Is BROWN & BURK UK LIMITED an active company?

BROWN & BURK UK LIMITED (company number 04082256) is recorded as "Active", incorporated on 2 Oct 2000.

What does BROWN & BURK UK LIMITED do?

Its Companies House nature-of-business (SIC) is: 21200 - Manufacture of pharmaceutical preparations.

Has BROWN & BURK UK LIMITED won UK public-sector contracts?

Yes — 44 public-sector contract awards are linked to this company in our data.

Where is BROWN & BURK UK LIMITED based?

Its registered office is MICRO HOUSE, HOUNSLOW, MIDDLESEX, TW4 5DQ.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable